Published in Am J Dig Dis on December 01, 1969
Viewpoints on the way to a consensus session: where does insulin resistance start? The liver. Diabetes Care (2009) 1.10
Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma. Gut (2002) 0.88
Stimulation of insulin secretion by medium-chain triglycerides in patients with cirrhosis. Gut (1971) 0.79
Hepatogenous diabetes: Is it a neglected condition in chronic liver disease? World J Gastroenterol (2016) 0.76
Some clinical features of liver cell failure: an appraisal of their causes. Gut (1978) 0.75
Analyses of RBC insulin receptor bindings in chronic liver disease. Korean J Intern Med (1986) 0.75
Morbidity and mortality of portal hypertension. Drugs (1989) 0.75
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med (1991) 12.09
The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods. Control Clin Trials (1985) 6.22
Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther (1969) 4.24
Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med (1976) 3.19
Cyclic AMP-dependent protein kinase phosphorylates and inactivates the yeast transcriptional activator ADR1. Cell (1989) 3.11
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology (1990) 2.99
Liver disease associated with secondary syphilis. N Engl J Med (1971) 2.51
A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology (1989) 2.40
Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science (1993) 2.36
Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Baltimore) (1971) 2.26
Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet (1985) 2.26
Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis (1977) 2.15
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology (1977) 2.10
Anterior subluxation of the lateral tibial plateau. A diagnostic test and operative repair. J Bone Joint Surg Am (1978) 2.10
Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology (1985) 2.09
Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol (1990) 2.07
Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants. Hepatology (1989) 2.05
Prophylactic portacaval anastomosis. Medicine (Baltimore) (1972) 1.99
Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med (1999) 1.96
Population differences of fetal biophysical and behavioral characteristics. Am J Obstet Gynecol (1992) 1.92
Pituitary adenoma. Preoperative symptomatology in a series of 260 patients. Br J Ophthalmol (1968) 1.89
A multicenter measurement of magnetization transfer ratio in normal white matter. J Magn Reson Imaging (1999) 1.76
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Diurnal variations in the human host response to endotoxin. J Infect Dis (1996) 1.71
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology (1983) 1.67
A rational approach to the hepatorenal syndrome. Gastroenterology (1973) 1.63
Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol (1997) 1.55
Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge. J Infect Dis (1999) 1.54
Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology (1979) 1.52
Therapeutic portacaval anastomosis: to shunt or not to shunt. Gastroenterology (1974) 1.50
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis (1978) 1.47
Solventogenic enzymes of Clostridium acetobutylicum: catalytic properties, genetic organization, and transcriptional regulation. FEMS Microbiol Rev (1995) 1.45
Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology (1988) 1.45
A randomized trial of prostaglandin E2 in a controlled-release vaginal pessary for cervical ripening at term. Am J Obstet Gynecol (1992) 1.44
Patterns of response to repeated total sleep deprivations in depression. J Affect Disord (2001) 1.44
Ammonia tolerance in the diagnosis of esophageal varices. A comparison of endoscopic, radiologic, and biochemical techniques. J Lab Clin Med (1967) 1.43
Enhanced expression of factor XII (Hageman factor) in isolated livers of estrogen- and prolactin-treated rats. J Lab Clin Med (1991) 1.42
Major bleeding complications after cardiopulmonary resuscitation: impact of thrombolytic treatment. J Intern Med (2003) 1.42
RedSoar--a system for red blood cell antibody identification. Proc Annu Symp Comput Appl Med Care (1991) 1.41
Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology (2000) 1.41
Transjugular intrahepatic portosystemic shunts versus sclerotherapy: a discussion of discordant results. Ann Intern Med (1997) 1.40
Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology (1995) 1.38
Evidence for x-linked dominant inheritance of ornithine transcarbamylase deficiency. N Engl J Med (1973) 1.37
Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial. N Engl J Med (1969) 1.35
Esophageal tamponade in the treatment of bleeding varices. A decadel progress report. Dig Dis Sci (1980) 1.34
A peek at the Child-Turcotte classification. Hepatology (1982) 1.34
Quantification of regional intrapulmonary oxygen partial pressure evolution during apnea by (3)He MRI. J Magn Reson (1999) 1.34
Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT--initial experience. Radiology (1999) 1.32
Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci U S A (1992) 1.29
Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting. N Engl J Med (1974) 1.29
Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology (1975) 1.28
Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Med Clin North Am (1975) 1.27
Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology (1981) 1.24
Selective intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage. Gastroenterology (1972) 1.23
Increased incidence of cholelithiasis in Laënnec's cirrhosis. A postmortem evaluation of pathogenesis. Gastroenterology (1972) 1.22
Ideal treatment of portal hypertension in 1985. Clin Gastroenterol (1985) 1.21
Fetal neurobehavioral development. Child Dev (1996) 1.20
Current challenges and opportunities for better integration of human factors research with development of clinical information systems. Yearb Med Inform (2009) 1.18
Portal-systemic encephalopathy and portacaval anastomosis: a prospective, controlled investigation. Gastroenterology (1974) 1.16
Fetal death without preceding fetal movement. N Engl J Med (1980) 1.15
A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines. Mol Cell Biol (2001) 1.15
Transcription of the testis-specific mouse protamine 2 gene in a homologous in vitro transcription system. Proc Natl Acad Sci U S A (1990) 1.14
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology (1998) 1.12
Dual-energy CT angiography of the lung in patients with suspected pulmonary embolism: initial results. Rofo (2008) 1.11
Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med (2000) 1.11
Chronic toxicity/oncogenicity evaluation of 60 Hz (power frequency) magnetic fields in F344/N rats. Toxicol Pathol (1999) 1.10
Paraneoplastic hypercalcemia in ovarian tumors. Obstet Gynecol (1979) 1.10
Structure and chromosomal localization of the human homeobox gene Prox 1. Genomics (1996) 1.10
Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci (1980) 1.09
Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment? Hepatology (2001) 1.09
Chronic toxicity/oncogenicity evaluation of 60 Hz (power frequency) magnetic fields in B6C3F1 mice. Toxicol Pathol (1999) 1.09
Elevated serum human chorionic gonadotropin as evidence of secretory response in severe preeclampsia. Am J Obstet Gynecol (1994) 1.09
The association between occupational factors and preterm birth: a United States nurses' study. Research Committee of the Association of Women's Health, Obstetric, and Neonatal Nurses. Am J Obstet Gynecol (1995) 1.09
Short-term effects of propranolol on portal venous pressure. Hepatology (1986) 1.08
The syndrome of methoxyflurane-associated hepatitis. Ann Intern Med (1974) 1.08
Percutaneous versus peritoneoscopic liver biopsy. Gastroenterology (1972) 1.07
Regulation of nitrogenase gene expression in anaerobic cultures of Anabaena variabilis. J Bacteriol (1988) 1.06
Development of fetal movement--fetal heart rate coupling from 20 weeks through term. Early Hum Dev (1996) 1.06
Limited wrist arthrodesis. Part II: Intercarpal and radiocarpal combinations. J Hand Surg Am (1981) 1.05
gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem (1995) 1.04
Lactulose. Gut (1970) 1.04
Analysis of ascitic fluid in cirrhosis. Dig Dis Sci (1979) 1.04
Checkrein resection for flexion contracture of the middle joint. J Hand Surg Am (1979) 1.04
Nocturnal sleep in Huntington's disease. J Neurol (1991) 1.03
Endoscopic sclerotherapy: an analysis of variants. Hepatology (1983) 1.03
(3)he-MRI-based measurements of intrapulmonary p(O2) and its time course during apnea in healthy volunteers: first results, reproducibility, and technical limitations. NMR Biomed (2000) 1.03
A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices. Gastroenterology (1979) 1.02
Tyrosine metabolism in patients with liver disease. J Clin Invest (1967) 1.02
Is hepatic scanning overated? Gastroenterology (1968) 1.01
Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family. Immunology (1992) 1.01
Adrenocorticosteroid administration and peptic ulcer: a critical analysis. J Chronic Dis (1985) 1.00
Comparison of the histologic and cytologic diagnosis of liver biopsies in hepatic cancer. Gastroenterology (1979) 1.00
Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc Natl Acad Sci U S A (1997) 1.00
Spontaneous meningococcal peritonitis: a report of two cases. Am J Dig Dis (1978) 1.00
Pituitary adenoma: results of combined surgical and radiotherapeutic treatment of 260 patients. Br Med J (1967) 0.99
Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation. Proc Natl Acad Sci U S A (1994) 0.99
Hepatic injury caused by L-alpha-methyldopa. Circulation (1969) 0.99